Helicobacter pylori Infection: Detection and Novel Treatment

Dear Colleagues,

Helicobacter pylori has long been recognized as a formidable player in the realm of gastrointestinal health, significantly impacting the global burden of digestive and various extragastric diseases. The complexity of H. pylori infection necessitates continuous exploration and innovation in diagnostic techniques and treatment modalities.

In this collection of articles, we bring together a diverse range of contributions that highlight groundbreaking research aiming to not only enhance our ability to accurately detect the bacterium in different clinical contexts, but also pioneer innovative therapeutic approaches designed to address antibiotic resistance and optimize patient outcomes. From long-established diagnostic methods such as serology and endoscopy to cutting-edge technologies such as next-generation sequencing, this Special Issue offers a novel perspective on their evolving role in precision medicine and personalized treatment plans. Furthermore, alternative therapeutic avenues, including the use of bacteriophages, probiotics and plant-derived compounds, vaccines and nanotechnology, emerge as promising areas of research explored for their potential in preventing and treating H. pylori-associated diseases.

We anticipate that this compilation will serve as a valuable resource for researchers, clinicians and policymakers, fostering a deeper understanding of the latest advancements, challenges and breakthroughs in the dynamic landscape of Helicobacter pylori research, ultimately paving the way for improved patient care and public health outcomes.

Dr. Evangelos Kazakos
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Helicobacter pylori
• gastrointestinal health
• antibiotic resistance
• infection